Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.
1. A method of stereoselective or regioselective synthesis through ring opening of aziridinium ions, comprising:
converting a substituted β amino alcohol to a substituted alkylating agent, wherein the substituted alkylating agent is a substituted β-amino halide comprising:
converting the substituted alkylating agent in the presence of halosequestering agent comprising AgClO 4 , AgOTf, Ag 2 CO 3 , AgOTs, AgNO 3 , AgSbF 6 , or AgBF 4 to a substituted aziridinium ion selected from:
where: Y is a non-nucleophilic counter anion or a leaving group comprising halide, perchlorate, tetrafluoroborate, hexafluoroantimonate, mesylate, triflate, carbonate, nitrate, phthalimide, or succinimide; each of R 1-4 independently is hydrogen, carboxyalkyl, alkylamido, alkyl, allyl, benzyl, benzyloxyalkyl, cycloalkyl, heterocyclyl, alkoxy, hydroxyalkyl, aryl, CH 2 Ar, aryloxy, hydroxyaryl, heteroaryl, phenyl, vinyl, alkynyl, alkenyl, substituted carbonyl, halo, haloalkyl, nitrile, oxo, substituted oxo, substituted silyl, thiol, benzhydryl, silyl, substituted carboxyl, aminoalkyl, alkoxycarbonyl, alkylamido, furannylalkyl, alkylthioalkyl, arylhydroxyalkyl, indanyl, indolylalkyl, naphthylalkyl, imidazolylalkyl, pyridiylalkyl, phthalimidyl, maleimidyl, benzothiophenylalkyl, thiophenylalkyl, thioalkyl, thioaryl, thiobenzyl, hydroxy, tosyl, nosyl, a protected amine, carboxyl, carboxyalkyloxy, amino, carboxylic acid, haloalkylamido, aldehyde, alkylamino, amido, trityl, tert-butyloxycarbonyl, carbobenzyloxy, acetyl, dimethoxybenzyl, p-methoxybenzyl, any two vicinal carbons of R 1 and R 2 together form a fused ring, any two geminal carbons, R 1 and R 2 are bonded together and form a spiro ring, any of R 1-4 is attached to chiral carbon, or is one of:
where n=1-10 and X is hydrogen, halo, cyano, alkyl, aryl, hydroxyl, nitro, amino, alkylamino, dialkylamino, substituted amine, substituted carbonyl, isocyanate, cyanate ester, protected amine, protected hydroxyl, protected carboxyl, boronic acid, borinic acid, borinate ester, triflate, silyl, substituted silyl, thiocyano, isothiocyano, alkoxy, aryloxy, carboxyl, carboxylic acid, carboxyalkyl, carboxyalkyloxy, ester, amido, aldehydo, alkylamido, or haloalkylamido, and/or R 3 or R 4 can also be selected from:
where n=1-3 and Ar is an aromatic ring bonded to one of the n carbons; R 5 is as defined for R 1 -R 4 ; R′ independently is OH, NH 2 , NR″ 2 , or OR″, wherein R″ independently is alkyl, tert-butyl, allyl, benzyl, CH 2 Ar, silyl, trityl, an amine protecting group, a carboxyl protecting group, or a hydroxyl protecting group; and wherein Ar in CH 2 Ar represents an aromatic rind; and
stereoselectively or regioselectively reacting the aziridinium ion in situ with a nucleophile in a nucleophilic ring opening reaction to obtain a compound, wherein the compound comprises one of:
where: n=1, 2, or 3; Y=O, NH, or S; each of each of R 1-5 and X are as defined above, and R 6 is as defined for R 1-5 .
2. The method of claim 1 , further comprising stereoselectively or regioselectively reacting the aziridinium ion in the presence of a catalyst.
3. The method of claim 2 , wherein the catalyst comprises a Lewis acid, an organocatalyst, or combinations thereof.
4. The method of claim 1 , wherein the synthesis occurs without isolation of any intermediate compound.